Home
About
Invest
Press
Contact
CEO Blog

News

nUro, Inc. Announces Name Change to Nuviant Medical, Receipt of CPRIT Award as Part of $1.45M Incontinence Program, and Appointment of David Kaysen to Board of Directors

[fa icon="calendar'] May 28, 2015 / by admin posted in Nuviant Medical, Neurostimulation, Urinary Incontinence, Grants & Funding, Implantable Devices

[fa icon="comment"] 0 Comments

Company positioned to expand incontinence program

DALLAS, May. 28, 2015 /PRNewswire-iReach/ -- nUro, Inc., a medical device development and manufacturing company creating neurostimulation solutions for neurological diseases, announced today that it is changing its name

Read More [fa icon="long-arrow-right"]

All posts

Subscribe to Email Updates

Recent
Popular
Categories

Nexeon MedSystems Founder, Director, & Chief Innovation Officer Dr. Mark C. Bates Awarded Leader In EndoVascular Education Award

posted at Aug 20, 2016

Nexeon MedSystems Files Form 10 Registration Statement

posted at Aug 18, 2016

Nuviant Medical Names Brian Blischak Chief Commercial Officer

posted at Mar 16, 2016

Nuviant Medical’s Neurostimulation System Selected by GlaxoSmithKline for Research in Bioelectronic Medicine

posted at Feb 16, 2016

Nuviant Medical Receives €3.4M from BioWin to Further Advance Closed Loop Neurostimulation System for E-Health Initiative

posted at Jan 10, 2016

Nexeon MedSystems Files Form 10 Registration Statement
MicroTransponder developing neurostimulation technology to allow tinnitus and stroke victims to re-train their brains
Nuviant Medical Names Brian Blischak Chief Commercial Officer
Nexeon MedSystems Founder, Director, & Chief Innovation Officer Dr. Mark C. Bates Awarded Leader In EndoVascular Education Award
Nuviant Medical’s Neurostimulation System Selected by GlaxoSmithKline for Research in Bioelectronic Medicine
Nuviant Medical Receives €3.4M from BioWin to Further Advance Closed Loop Neurostimulation System for E-Health Initiative
MicroTransponder Clinical Trial Results Published in Stroke After Company Completes a $5.5M Round of Funding
Nuviant Medical Awarded $175k NIH SBIR Grant to Develop Treatment for Dysphagia
A trial at the U of M is helping stroke victims regain their strength
Team Wins DARPA Grant to Explore Potential Treatment for PTSD

Lists by Topic

see all

Posts by Topic

see all

Recent Posts

Nexeon MedSystems Founder, Director, & Chief Innovation Officer Dr. Mark C. Bates Awarded Leader In EndoVascular Education Award
Nexeon MedSystems Files Form 10 Registration Statement
Nuviant Medical Names Brian Blischak Chief Commercial Officer
Nuviant Medical’s Neurostimulation System Selected by GlaxoSmithKline for Research in Bioelectronic Medicine
Nuviant Medical Receives €3.4M from BioWin to Further Advance Closed Loop Neurostimulation System for E-Health Initiative
MicroTransponder developing neurostimulation technology to allow tinnitus and stroke victims to re-train their brains
A trial at the U of M is helping stroke victims regain their strength
Nuviant Medical Awarded $175k NIH SBIR Grant to Develop Treatment for Dysphagia
MicroTransponder Clinical Trial Results Published in Stroke After Company Completes a $5.5M Round of Funding
MicroTransponder Clinical Trial Results Published in Stroke after Company Completes a $5.5M Round of Funding

Empowering patients to be free.

Nexeon is a bioelectronics company developing and manufacturing medical devices and the software platforms that support the remote management of these devices.

Learn More [fa icon="long-arrow-right"]

More Links

[fa icon="caret-right"] Home
[fa icon="caret-right"] Blog
[fa icon="caret-right"] About Us
[fa icon="caret-right"] Contact Us

Contact Us

[fa icon="phone"] 844-919-9990

[fa icon="envelope"] [email protected]

[fa icon="home"] 1708 Jaggie Fox Way, Lexington KY 40511

[fa icon="facebook-square"]Facebook [fa icon="linkedin-square"]Linkedin [fa icon="twitter-square"]Twitter [fa icon="pinterest-square"]Pinterest

Copyright 2016 | All Rights Reserved. | Caution: Limited by United States law to investigational use only.

[fa icon="chevron-up"]Back to top